NEW YORK (GenomeWeb News) – The UK is investing £12 million ($19.9 million) to establish new synthetic biology facilities and provide training in the field, the Biotechnology and Biological Sciences Research Council announced on Wednesday.

The UK Research Councils, led by BBSRC, will award £10 million to create five DNA synthesis centers "to further develop the UK's research base in synthetic biology," BBSRC said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.